Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an example

Environment International

Volumn 85, Issue , 2015, Pages 327-333

  Acuna V ^a   Ginebreda, A ^b   Mor, J R ^a   Petrovic, M ^a,c   Sabater, S ^a,d   Sumpter, J ^e   Barcelo D ^a,b  

^a CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d UNIVERSITY OF GIRONA   (Spain)

^e BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Diclofenac; Ecotoxicity; Environmental policies; Environmental risks; Freshwater ecosystems; Pharmaceuticals

Indexed keywords

DRUG PRODUCTS; HEALTH RISKS; VETERINARY MEDICINE; WATER;

DICLOFENAC; ECOTOXICITY; ENVIRONMENTAL POLICY; ENVIRONMENTAL RISKS; FRESHWATER ECOSYSTEM;

ENVIRONMENTAL PROTECTION;

DICLOFENAC; FRESH WATER; NONSTEROID ANTIINFLAMMATORY AGENT; WATER POLLUTANT;

DRUG; ECOTOXICOLOGY; ENVIRONMENTAL EFFECT; ENVIRONMENTAL POLICY; ENVIRONMENTAL RISK; FRESHWATER ECOSYSTEM; TOXICITY;

ARTICLE; CONTROLLED STUDY; DRUG USE; ECOTOXICITY; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL PLANNING; FRESHWATER ENVIRONMENT; HUMAN; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; WATER ANALYSIS; WATER POLLUTION; ANALYSIS; ANIMAL; DRUG UTILIZATION; ECOSYSTEM; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK; STATISTICS AND NUMERICAL DATA; TOXICITY; WATER POLLUTANT;

ANIMALIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DRUG UTILIZATION; ECOSYSTEM; ENVIRONMENTAL POLICY; FRESH WATER; HUMANS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; RISK; WATER POLLUTANTS, CHEMICAL;

EID: 84943597515     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2015.09.023     Document Type: Article

References (48)

1. Ågerstrand M., Berg C., Björlenius B., Breitholtz M., Brunstrom B., Fick J., Gunnarsson L., Larsson D.G.J., Sumpter J.P., Tysklind M., Rudén C. Improving environmental risk assessment of human pharmaceuticals. Environ. Sci. Technol. 2015, (150406115258002).
2. Agüera A., Pérez Estrada L.A., Ferrer I., Thurman E.M., Malato S., Fernández-Alba A.R. Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. J. Mass Spectrom. 2005, 40:908-915.
3. Bach S. Effekte von Diclofenac und komplexen Belastungen im Freiland auf die Entwicklung der Bachforelle (Salmo trutta f. fario) 2004, Universität Tübingen, Germany.
4. Balmford A. Ecology. Pollution, politics, and vultures. Science 2013, 339:653-654.
5. Boxall A.B.A., Rudd M.A., Brooks B.W., Caldwell D.J., Choi K., Hickmann S., Innes E., Ostapyk K., Staveley J.P., Verslycke T., Ankley G.T., Beazley K.F. Review pharmaceuticals and personal care products in the environment: what are the big questions?. Environ. Health Perspect. 2012, 120:1221-1229.
6. Caldwell D.J., Mastrocco F., Margiotta-Casaluci L., Brooks B.W. An integrated approach for prioritizing pharmaceuticals found in the environment for risk assessment, monitoring and advanced research. Chemosphere 2014, 115:4-12.
7. Carson R.L. Silent spring 1962, Houghton Mifflin, Boston, New York, U.S.A.
8. Chemical Abstracts Service, C., n.d., Regulated chemicals - CHEMLIST [WWW document]. URL ref (accessed 4.23.15). http://www.cas.org/content/regulated-chemicals.
9. Corcoll N., Casellas M., Huerta B., Guasch H., Acuña V., Rodríguez-Mozaz S., Serra-Compte A., Barceló D., Sabater S. Effects of flow intermittency and pharmaceutical exposure on the structure and metabolism of stream biofilms. Sci. Total Environ. 2015, 503-504:159-170.
10. Council of the European Communities Directive 2000/60/EEC establishing a framework for the community action in the field of water policy (EEU Water Framework Directive). Off. J. Eur. Union 2000, L327:1.
11. Council of the European Communities Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy. Off. J. Eur. Union 2013, L226:1-17.
12. Dietrich S., Ploessl F., Bracher F., Laforsch C. Single and combined toxicity of pharmaceuticals at environmentally relevant concentrations in Daphnia magna-a multigenerational study. Chemosphere 2010, 79:60-66.
13. Eades C., Waring C.P. The effects of diclofenac on the physiology of the green shore crab Carcinus maenas. Mar. Environ. Res. 2010, 69(Suppl.):S46-S48.
14. EMEA Guideline on the environmental risk assessment of medicinal products for human use 2006, United Kingdom, London.
15. EMEA Guideline on environmental impact assessment for veterinary medicinal products in support of the VICH guidelines GL6 and GL38 2007.
16. European Comission General Union environment action programme to 2020. Living Well, Within the Limits of our Planet 2014, (Luxembourg).
17. Feito R., Valcárcel Y., Catalá M. Biomarker assessment of toxicity with miniaturised bioassays: diclofenac as a case study. Ecotoxicology 2012, 21:289-296.
18. Felice B.D., Copia L., Guida M. Gene expression profiling in zebrafish embryos exposed to diclofenac, an environmental toxicant. Mol. Biol. Rep. 2012, 39:2119-2128.
19. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
20. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Saf. 2003, 55:359-370.
21. Haap T., Triebskorn R., Köhler H.-R. Acute effects of diclofenac and DMSO to Daphnia magna: immobilisation and hsp70-induction. Chemosphere 2008, 73:353-359.
22. Hallare A.V., Köhler H.-R., Triebskorn R. Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 2004, 56:659-666.
23. Hong H.N., Kim H.N., Park K.S., Lee S.-K., Gu M.B. Analysis of the effects diclofenac has on Japanese medaka (Oryzias latipes) using real-time PCR. Chemosphere 2007, 67:2115-2121.
24. Huerta B., Jakimska A., Llorca M., Ruhí A., Margoutidis G., Acuña V., Sabater S., Rodriguez-Mozaz S., Barcelò D. Development of an extraction and purification method for the determination of multi-class pharmaceuticals and endocrine disruptors in freshwater invertebrates. Talanta 2015, 132:373-381.
25. Hughes S.R., Kay P., Brown L.E. Global synthesis and critical evaluation of pharmaceutical data sets collected from river systems. Environ. Sci. Technol. 2013, 47:661-677.
26. Johnson A.C., Dumont E., Williams R.J., Oldenkamp R., Cisowska I., Sumpter J.P. Do concentrations of ethinylestradiol, estradiol, and diclofenac in European rivers exceed proposed EU environmental quality standards?. Environ. Sci. Technol. 2013, 47:12297-12304.
27. Johnson A.C., Sumpter J.P. Putting pharmaceuticals into the wider context of challenges to fish populations in rivers. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369:20130581.
28. Kotwani A. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all. BMC Health Serv. Res. 2013, 13:285.
29. Lahti M., Brozinski J.-M., Jylhä A., Kronberg L., Oikari A. Uptake from water, biotransformation, and biliary excretion of pharmaceuticals by rainbow trout. Environ. Toxicol. Chem. 2011, 30:1403-1411.
30. Lawrence J.R., Swehone G.D.W., Topp E., Korber D.R., Neu T.R., Wassenaar L.I. Structural and functional responses of river biofilm communities to the nonsteroidal anti-inflammatory Diclofenac. Environ. Toxicol. Chem. 2007, 26:573-582.
31. Lutz W., Sanderson W., Scherbov S. The coming acceleration of global population ageing. Nature 2008, 451:716-719.
32. Mehinto A.C., Hill E.M., Tyler C.R. Uptake and biological effects of environmentally relevant concentrations of the nonsteroidal anti-inflammatory pharmaceutical diclofenac in rainbow trout (Oncorhynchus mykiss). Environ. Sci. Technol. 2010, 44:2176-2182.
33. Nassef M., Matsumoto S., Seki M., Khalil F., Kang I.J., Shimasaki Y., Oshima Y., Honjo T. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 2010, 80:1095-1100.
34. Ort C., Hollender J., Schaerer M., Siegrist H. Model-based evaluation of reduction strategies for micropollutants from wastewater treatment plants in complex river networks. Environ. Sci. Technol. 2009, 43:3214-3220.
35. Parolini M., Binelli A., Cogni D., Riva C., Provini A. An in vitro biomarker approach for the evaluation of the ecotoxicity of non-steroidal anti-inflammatory drugs (NSAIDs). Toxicol. in Vitro 2009, 23:935-942.
36. Praskova E., Plhalova L., Chromcova L., Stepanova S., Bedanova I., Blahova J., Hostovsky M., Skoric M., Maršálek P., Voslarova E., Svobodova Z. Effects of subchronic exposure of diclofenac on growth, histopathological changes, and oxidative stress in zebrafish (Danio rerio). Sci. World J. 2014, 2014.
37. Richardson, S.D., Ternes, T. a, 2014. Water analysis: emerging contaminants and current issues. Anal. Chem. 86, 2813-48.
38. Risebrough R. Conservation biology: fatal medicine for vultures. Nature 2004, 427:596-598.
39. Saravanan M., Karthika S., Malarvizhi A., Ramesh M. Ecotoxicological impacts of clofibric acid and diclofenac in common carp (Cyprinus carpio) fingerlings: hematological, biochemical, ionoregulatory and enzymological responses. J. Hazard. Mater. 2011, 195:188-194.
40. Saravanan M., Ramesh M. Short and long-term effects of clofibric acid and diclofenac on certain biochemical and ionoregulatory responses in an Indian major carp, Cirrhinus mrigala. Chemosphere 2013, 93:388-396.
41. Schmidt W., O'Rourke K., Hernan R., Quinn B. Effects of the pharmaceuticals gemfibrozil and diclofenac on the marine mussel (Mytilus spp.) and their comparison with standardized toxicity tests. Mar. Pollut. Bull. 2011, 62:1389-1395.
42. Schulze T., Weiss S., Schymanski E., von der Ohe P.C., Schmitt-Jansen M., Altenburger R., Streck G., Brack W. Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis. Environ. Pollut. 2010, 158:1461-1466.
43. Schwaiger J., Ferling H., Mallow U., Wintermayr H., Negele R.D. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: histopathological alterations and bioaccumulation in rainbow trout. Aquat. Toxicol. 2004, 68:141-150.
44. Stepanova S., Praskova E., Chromcova L., Plhalova L., Prokes M., Blahova J., Svobodova Z. The effects of diclofenac on early life stages of common carp (Cyprinus carpio). Environ. Toxicol. Pharmacol. 2013, 35:454-460.
45. Triebskorn R., Casper H., Heyd A., Eikemper R., Köhler H.-R., Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part II: cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2004, 68:151-166.
46. Triebskorn R., Casper H., Scheil V., Schwaiger J. Ultrastructural effects of pharmaceuticals (carbamazepine, clofibric acid, metoprolol, diclofenac) in rainbow trout (Oncorhynchus mykiss) and common carp (Cyprinus carpio). Anal. Bioanal. Chem. 2007, 387:1405-1416.
47. United States Environmental Protection Agency National Recommended Water Quality Criteria 1999, (Washington DC).
48. Vieno N., Sillanpää M. Fate of diclofenac in municipal wastewater treatment plant - a review. Environ. Int. 2014, 69:28-39.